St. John's School is ranked the No. 2 private high school in Texas. St. John's School.org

Several Houston-area school are among the top of their class among public and private high schools in Texas.

New rankings from education website Niche put three local institutions among the top public high schools in the state and four among the top private high schools in the state.

Carnegie Vanguard High School (in Houston ISD) leads the area best public high schools, while our prestigious St. John's School leads the private academies.

Niche ranks public high schools based on factors such as state test scores, college readiness, graduation rates, SAT/ACT scores, teacher quality, and Niche user ratings.

Meanwhile, Niche ranks private high schools based on factors like SAT/ACT scores, quality of colleges that students consider, student-teacher ratio, and Niche user ratings.

"Our 2022 rankings come at a time when so many parents are curious about the different options for their children's education, including some they may never have considered before," Luke Skurman, founder and CEO of Niche, says in a news release.

Other local schools also ranked well:

  • Top-ranked School for the Talented and Gifted (Dallas ISD).
  • Second-ranked Liberal Arts & Science Academy (Austin ISD).
  • Third-ranked School of Science and Engineering (Dallas ISD).
  • Fourth-ranked Westlake High School (Eanes ISD).
  • Fifth-ranked Carnegie Vanguard High School (Houston ISD).
  • Sixth-ranked DeBakey High School for Health Professions (Houston ISD).
  • Seventh-ranked Carroll Senior High School (Carroll ISD).
  • Eighth-ranked Westwood High School (Round Rock ISD).
  • Ninth-ranked Kinder High School for the Performing and Visual Arts (Houston ISD).
  • 10th-ranked Vandegrift High School (Leander ISD).

The top private high schools in Texas are:

  • Top-ranked St. Mark's School of Texas in Dallas.
  • Second-ranked St. John's School in Houston.
  • Third-ranked Greenhill School in Addison.
  • Fourth-ranked The Hockaday School in Dallas.
  • Fifth-ranked St. Stephen's Episcopal School in Austin.
  • Sixth-ranked The John Cooper School in The Woodlands.
  • Seventh-ranked The Awty International School in Houston.
  • Eighth-ranked Keystone School in San Antonio.
  • Ninth-ranked Cistercian Preparatory School in Irving.
  • 10th-ranked The Kincaid School in Houston.

As for the best school districts in Texas, they are:

  • Top-ranked Eanes ISD in Austin.
  • Second-ranked South Texas ISD in Mercedes.
  • Third-ranked Highland Park ISD in Dallas.
  • Fourth-ranked Carroll ISD in Southlake.
  • Fifth-ranked Coppell ISD in Coppell.
  • Sixth-ranked Lovejoy ISD in Allen.
  • Seventh-ranked Frisco ISD in Frisco.
  • Eighth-ranked Argyle ISD in Argyle.
  • Ninth-ranked Grapevine-Colleyville ISD in Grapevine.
  • 10th-ranked Allen ISD in Allen.
------
This article originally ran on CultureMap.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.